SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 238 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 0.95 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,085 | -99.9% | 8,370 | -31.6% | 0.11% | -4.4% |
| Q1 2022 | $956,000 | +231.9% | 12,240 | +229.9% | 0.11% | +289.7% |
| Q2 2021 | $288,000 | -67.7% | 3,710 | -50.4% | 0.03% | -80.1% |
| Q1 2019 | $891,000 | +217.1% | 7,478 | +97.2% | 0.15% | +247.6% |
| Q1 2018 | $281,000 | +28.9% | 3,792 | -41.3% | 0.04% | +2.4% |
| Q2 2017 | $218,000 | +4.3% | 6,462 | -8.2% | 0.04% | -16.3% |
| Q1 2017 | $209,000 | – | 7,038 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ghost Tree Capital, LLC | 290,000 | $44,066,000 | 9.14% |
| Avoro Capital Advisors LLC | 1,400,000 | $212,730,000 | 7.35% |
| NEXTHERA CAPITAL LP | 50,317 | $7,646,000 | 6.37% |
| Eventide Asset Management | 1,123,000 | $170,640,000 | 5.19% |
| RTW INVESTMENTS, LP | 604,236 | $91,814,000 | 4.90% |
| Casdin Capital, LLC | 335,000 | $50,903,250,000 | 4.76% |
| Copernicus Capital Management, LLC | 30,000 | $4,559,000 | 4.06% |
| CADIAN CAPITAL MANAGEMENT, LP | 548,500 | $83,345,000 | 3.76% |
| Camber Capital Management LP | 500,000 | $75,975,000 | 3.54% |
| Dynamic Capital Management Ltd | 4,677 | $711,000 | 3.54% |